Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation: A Randomised Non-Inferiority Trial

Clinical Trial | By DR Holmes, VY Reddy, PROTECT AF Investigators et al.

Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial

Clinical Trial | By VY Reddy, SK Doshi, PROTECT AF Investigators et al.

Contrast-Associated Acute Kidney Injury and Serious Adverse Outcomes Following Angiography

Original Research | By SD Weisbord, PM Palevsky, the PRESERVE Trial Investigators et al.

2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques

Original Research | By MHwa Yamamoto, A Maehara, GW Stone et al.

Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct Administration

Original Research | By G Mendieta, S Ben-Aicha, M Gutiérrez et al.

Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk

Original Research | By S Windecker, A Latib, the ONYX ONE Investigators et al.

Randomized Comparison of Everolimus- and Zotarolimus-Eluting Coronary Stents With Biolimus-Eluting Stents in All-Comer Patients

Clinical Trial | By YJ Youn, J-W Lee, J Yoon et al.

Novel functions of macrophages in the heart: insights into electrical conduction, stress, and diastolic dysfunction

Expert Opinion | By F Leuschner, M Nahrendorf et al.

CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic

Consensus | By YL Han , HS Zeng , H Jiang et al.

Clopidogrel Pharmacogenetics: State-of-the-Art Review and the TAILOR-PCI Study

Review Article | By NL Pereira, CS Rihal, DYF So et al.